HIV News and Research

RSS

Six federal scientists run out by Trump talk about the work left undone

Marc Ernstoff, a physician who has pioneered immunotherapy research and treatments for cancer patients, said his work as a federal scientist proved untenable under the Trump administration.

6 Mar 2026

Spatial intelligence platform supports health policy decisions aimed at ending HIV

INCLIVA Healthcare Research Institute-University Clinical Hospital of Valencia, the Universitat Politècnica de València - through its VRAIN Institute, the Valencia Anti-AIDS Committee and the Centre for Epidemiological Studies on Sexually Transmitted Infections and AIDS in Catalonia (CEEISCAT) have joined forces to develop a spatial intelligence platform to support health policy decisions aimed at optimizing the prevention of human immunodeficiency virus (HIV) and accelerating its early diagnosis.

5 Mar 2026

Researchers identify immune markers linked to cognitive decline after viral infections

What impact does a viral infection have on our memory, attention, and concentration? The COVID-19 pandemic has reignited interest in this question, which has now been extended to other infections such as HIV, herpes, and hepatitis.

5 Mar 2026

AI pinpoints why vaccine responses vary globally

How people with compromised immune systems respond to vaccines is an important area of immunological research. A new study led by York University found that not only could machine-learning models accurately pinpoint differences in healthy controls and those living with HIV, but also found outliers in both groups that provide fascinating glimpses into the complex nature of the immune system and what personalized medicine could look like in the future, accounting for variables such as age, comorbidities and genetics.

4 Mar 2026

New HIV-seq tool advances understanding of persistent viral reservoirs

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and transmission.

3 Mar 2026

Acoziborole receives positive opinion for single-dose sleeping sickness treatment

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both early- and advanced-stage gambiense sleeping sickness in adults as well as in adolescents 12 years and older weighing at least 40 kilograms.

27 Feb 2026

Denmark achieves historic elimination of mother-to-child HIV and syphilis transmission

The World Health Organization (WHO) has certified Denmark for the elimination of mother-to-child transmission (EMTCT) of HIV and syphilis, recognizing the country's sustained commitment to ensuring every child is born free of these infections.

27 Feb 2026

Assessing the value of modern US healthcare gains

Over two decades, medical care improvements increased health spans in the U.S. by 1.3 years and medical spending by $234,000 per person over their lifetime – or about $182,000 per additional healthy year of life gained – when measured from birth. These are among the key findings in a new in-depth national study published today in Value in Health.

26 Feb 2026

New daily tablet simplifies long-term HIV care

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet.

26 Feb 2026

New single pill regimen simplifies treatment for resistant HIV

A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and lenacapavir (BIC/LEN) – may simplify treatment significantly for people with HIV who currently take very complex treatments.

25 Feb 2026

Breakthrough gene therapy for sickle cell disease remains out of reach in Africa

As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most patients in Africa.

25 Feb 2026

Researchers uncover vulnerabilities in elusive HIV reservoir clones

A new study has overcome a long-standing challenge-how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.

24 Feb 2026

Single-cell RNA sequencing reveals accelerated T cell aging in viral infections

A new research paper was published in Volume 18 of Aging-US on February 8, 2026, titled "Single-cell transcriptomics reveal intrinsic and systemic T cell aging in COVID-19 and HIV."

19 Feb 2026

Genome sequencing data reveals new insights into Epstein-Barr virus immunity

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown.

19 Feb 2026

Onset of "the munchies" after cannabis use could offer clues to help people with appetite loss

The urgent onset of "the munchies" after cannabis use isn't imaginary – it's a cognitive response that occurs regardless of sex, age, weight or recent food consumption and could offer clues to help people struggling with appetite loss.

19 Feb 2026

Study reveals previously unknown role for viral protein integrase in HIV's life cycle

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

18 Feb 2026

Fred Hutch scientists reach crucial milestone in blocking Epstein Barr virus

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative diseases and other chronic health conditions.

17 Feb 2026

UK aid cuts accelerate dangerous retreat from global health in crisis-affected regions

UK aid cuts demand justice-led solutions such as debt restructuring to repair the harm, writes Katie Husselby, director of Action for Global Health.

17 Feb 2026

Bioengineered E. coli bacteria can now produce rhododendron-derived drugs

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.

17 Feb 2026

Study quantifies the economic implications of living with HIV

A recent study, published in Nature Communications, shows that in the Netherlands, people who are diagnosed with HIV are less likely to be employed, work fewer hours, earn less income, and are more likely to receive disability benefits up to seven years after diagnosis.

16 Feb 2026

HIV News and Research

Six federal scientists run out by Trump talk about the work left undone

Spatial intelligence platform supports health policy decisions aimed at ending HIV

Researchers identify immune markers linked to cognitive decline after viral infections

AI pinpoints why vaccine responses vary globally

New HIV-seq tool advances understanding of persistent viral reservoirs

Acoziborole receives positive opinion for single-dose sleeping sickness treatment

Denmark achieves historic elimination of mother-to-child HIV and syphilis transmission

Assessing the value of modern US healthcare gains

New daily tablet simplifies long-term HIV care

New single pill regimen simplifies treatment for resistant HIV

Breakthrough gene therapy for sickle cell disease remains out of reach in Africa

Researchers uncover vulnerabilities in elusive HIV reservoir clones

Single-cell RNA sequencing reveals accelerated T cell aging in viral infections

Genome sequencing data reveals new insights into Epstein-Barr virus immunity

Onset of "the munchies" after cannabis use could offer clues to help people with appetite loss

Study reveals previously unknown role for viral protein integrase in HIV's life cycle

Fred Hutch scientists reach crucial milestone in blocking Epstein Barr virus

UK aid cuts accelerate dangerous retreat from global health in crisis-affected regions

Bioengineered E. coli bacteria can now produce rhododendron-derived drugs

Study quantifies the economic implications of living with HIV

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News